Stocks · Healthcare · Medical - Care Facilities
Strata Critical Medical, Inc. SRTA
$4.73 -2.07% Close, Oct 2, 2026 · NASDAQ · Market cap $409.3M
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The diluted share count rose 6.0% in a year.
- The company holds net cash of $12.1M (cash above total debt).
- Revenue over the last four quarters was $256.0M, up 0.6% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 30%
- Revenue growth, 3-year CAGRTop 50%
- Revenue growth accelerationBottom 48%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 40%
- Gross marginBottom 15%
- Operating marginBottom 49%
- Cash conversion (OCF / net income)Bottom 3%
- Accruals (lower is better)Bottom 4%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 3%
- Free-cash-flow yieldBottom 36%
- EBITDA / enterprise valueTop 44%
- Sales / enterprise valueTop 18%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 37%
- 6-month returnTop 44%
- 1-year return vs S&P 500Bottom 37%
- Distance from 52-week highTop 42%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 45%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 34%
- Maximum drawdown, 3 yearsTop 23%
- Beta vs S&P 500 (lower is better)Bottom 9%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1.1% | 0.6% | ↓ |
| Gross margin | 24.4% | 20.6% | ↓ |
| Operating margin | -9.6% | -8.0% | ↑ |
| FCF margin | -7.0% | -17.1% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 0.6% | 1.1% | ↓ | Bottom 30% |
| Gross margin | 20.6% | 24.4% | ↓ | Bottom 15% |
| Operating margin | -8.0% | -9.6% | ↑ | Bottom 49% |
| Net margin | 15.7% | -7.5% | ↑ | — |
| Free-cash-flow margin | -17.1% | -7.0% | ↓ | — |
| Return on invested capital | -7.1% | — | Top 40% | |
| Revenue growth, 3-year CAGR | 10.5% | — | Top 50% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -0.77×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 21.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +53.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.04%
- Shareholder yield
- -0.04%
- Share count change, 1 year
- +6.0%
- Share count change, 3-year CAGR
- +5.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +4.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $7.25
- Target vs current price
- +53.3%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -500.0% | +0.4% | +7.0% | +2.0% | — |
| May 6, 2026 | +175.0% | +10.6% | +13.5% | +28.8% | +4.1% |
| Mar 3, 2026 | -721.4% | +6.9% | +1.8% | -9.8% | +39.4% |
| Nov 10, 2025 | -200.0% | +9.5% | +8.1% | -1.1% | -0.7% |
| Aug 5, 2025 | -25.0% | -6.1% | -4.5% | -3.8% | +11.3% |
| May 12, 2025 | +63.6% | +18.5% | +20.5% | +45.2% | +32.5% |
| Mar 13, 2025 | +0.0% | +7.1% | +6.7% | -2.1% | +34.3% |
| Nov 12, 2024 | +50.0% | -8.9% | -19.1% | +17.0% | -2.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.12 | -$0.02 | -500.0% | $72.5M |
| May 6, 2026 | $0.03 | -$0.04 | +175.0% | $67.4M |
| Mar 3, 2026 | -$0.06 | $0.01 | -721.4% | $66.8M |
| Nov 10, 2025 | -$0.06 | -$0.02 | -200.0% | $49.3M |
| Aug 5, 2025 | -$0.05 | -$0.04 | -25.0% | $70.8M |
| May 12, 2025 | -$0.04 | -$0.11 | +63.6% | $54.3M |
| Mar 13, 2025 | -$0.12 | -$0.12 | +0.0% | $54.4M |
| Nov 12, 2024 | -$0.03 | -$0.06 | +50.0% | $74.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 9.5× | — | — | Top 3% |
| EV / Sales | 1.55× | — | — | Top 18% |
| Free-cash-flow yield | -10.68% | — | — | Bottom 36% |
| Earnings yield | 10.52% | — | — | Top 3% |
P/E over the past five years
Range 9.3× – 11.2× since Sep 30, 2025. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.1%
- 200-day average slope (20 days)
- +1.5%
- Distance from 50-day average
- -14.0%
- Distance from 200-day average
- -8.5%
- RSI (14)
- 30.1
- Relative volume
- 1.26×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 46.9%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.16
- Correlation with S&P 500
- 0.48
- Current drawdown from 1-year high
- -26.9%
- Maximum drawdown, 3 years
- -48.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | Nov 1, 2023 | -88.8% | 683 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $409.3M
- P/E (TTM)
- 9.5
- EPS, diluted (TTM)
- $0.50
- Revenue (TTM)
- $256.0M
- 52-week range
- $3.95 – $6.50
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $50.5M | $146.1M | $225.2M | $248.7M | $197.1M |
| Gross profit | $10.5M | $22.3M | $42.1M | $58.9M | $41.1M |
| Operating income | -$24.1M | -$53.5M | -$68.1M | -$33.9M | -$22.4M |
| Net income | -$40.1M | -$27.3M | -$56.1M | -$27.3M | $41.3M |
| EPS (diluted) | -$0.57 | -$0.38 | -$0.76 | -$0.35 | $0.50 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $74.9M | $54.4M | $54.3M | $70.8M | $49.3M | $66.8M | $67.4M | $72.5M |
| Net income | -$2.0M | -$9.8M | -$3.5M | -$3.7M | $57.4M | -$8.8M | $2.2M | -$10.5M |
| EPS (diluted) | -$0.03 | -$0.12 | -$0.04 | -$0.05 | $0.70 | -$0.11 | $0.03 | -$0.12 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$15.6M | -$37.1M | -$32.3M | -$2.5M | -$48.9M |
| Capital expenditure | -$297,000 | -$730,000 | -$2.1M | -$33.0M | -$11.0M |
| Free cash flow | -$15.9M | -$37.9M | -$34.5M | -$35.5M | -$59.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $144,000 | $87,000 | $70,000 | -$244,000 | $193,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $22.8M
- Total assets
- $332.7M
- Total liabilities
- $53.4M
- Total debt
- $4.3M
- Net debt
- -$12.1M
- Shareholders’ equity
- $279.3M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 4,358,719
- Days to cover
- 5.16
- Change vs previous report
- -3.7%
FINRA short interest, settlement date Sep 15, 2026.